Surgical Interventions and Advanced Options
At a Glance
Advanced tropical endomyocardial fibrosis may be treated with surgery to remove scar tissue and clots and repair or replace damaged valves; carefully selected patients may be evaluated for heart transplant. Timing, risks, and recovery depend on heart damage and overall health.
When medical treatments no longer effectively manage the symptoms of Tropical Endomyocardial Fibrosis (EMF), surgery may be considered. Surgery for EMF is a complex and high-stakes undertaking, but for properly selected patients with advanced disease, it offers a chance to significantly improve heart function and quality of life [1][2].
When is Surgery Recommended?
Doctors typically consider surgery when a patient reaches “advanced” stages of the disease, though NYHA class III or IV alone does not automatically determine the timing. Referral should occur before irreversible organ damage happens [1].
- NYHA Class III: You have significant limitations in physical activity; even simple tasks like walking across a room cause fatigue or breathlessness.
- NYHA Class IV: You are unable to carry out any physical activity without discomfort and may have symptoms even while resting [3][4].
Other triggers for surgery include severe leaking of the heart’s valves (regurgitation) or a rapidly declining ability to manage fluid buildup. Timing depends on anatomy, end-organ function, operative risk, and center experience [3][5].
The Standard Surgical Approach
The goal of EMF surgery is to “remake” the inside of the heart by removing the stiff scar tissue that prevents it from filling [6].
- Endocardectomy (Decortication): In this procedure, the surgeon carefully peels or “strips” the thick layer of fibrous scar tissue away from the inner lining of the heart’s ventricles [7][8]. This helps the heart muscle become more flexible so it can once again hold an adequate amount of blood [9].
- Thrombus Removal: If a blood clot (thrombus) has formed at the tip of the heart, it is removed during the same operation to prevent future strokes [10].
- Valve Surgery: Because the scar tissue often pulls on the heart’s valves, surgeons must either repair or replace the mitral or tricuspid valves [3]. Valve repair is often considered when feasible, but in many cases of EMF, the damage is so extensive that a full valve replacement is necessary [7]. Keep in mind that a mechanical valve usually requires lifelong anticoagulation therapy.
Understanding the Risks and Benefits
Surgery for EMF carries a higher risk than many other heart operations. It is important to have an honest discussion with your surgical team about these factors:
- Operative Mortality: Historically, the risk of not surviving the hospital stay following EMF surgery is significant. Large historical studies in specialized African centers have reported a hospital mortality rate of approximately 16% [7]. Current outcomes are variable and depend on the specific era and center.
- Symptom Improvement: For those who recover from surgery, functional improvement is very possible. Many patients move from being bedridden to being able to perform normal daily activities, though it is not guaranteed [10][11].
- Palliative and Supportive Care: For patients who are not surgical candidates, robust supportive and palliative care pathways should be in place to prioritize comfort.
Advanced Options: Heart Transplantation
In rare cases where the heart is too damaged for a “peeling” surgery, a heart transplant may be considered. This is a planned advanced-heart-failure pathway for carefully selected patients with refractory symptoms or severe biventricular/end-organ disease [5][12].
Transplantation should ideally be evaluated before an emergency crisis; it is not strictly reserved as a last-minute option for patients who are in cardiogenic shock [5]. While successful transplants have been reported, this option is often limited by the availability of donor hearts and the need for lifelong, complex follow-up care [13][12].
Post-Surgical Recovery
Recovery from EMF surgery is a gradual process. Common postoperative complications include bleeding and rhythm disturbances. Many patients eventually benefit from structured exercise rehabilitation programs, which must be prescribed individually, as they are not universally safe without tailored guidance [11].
Common questions in this guide
When is surgery considered for tropical endomyocardial fibrosis?
What happens during surgery for EMF?
Is valve repair or replacement better for endomyocardial fibrosis?
What are the risks and possible benefits of EMF surgery?
Can a heart transplant treat advanced tropical endomyocardial fibrosis?
What is recovery like after EMF surgery?
Get notified when new evidence is published on Tropical endomyocardial fibrosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery.
Negri F, Fabris E, Masè M, et al.
Journal of cardiac surgery 2020; (35(2)):460-463 doi:10.1111/jocs.14378.
PMID: 31778572 - 2
Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives.
Grimaldi A, Mocumbi AO, Freers J, et al.
Circulation 2016; (133(24)):2503-15 doi:10.1161/CIRCULATIONAHA.115.021178.
PMID: 27297343 - 3
Endomyocardial fibrosis.
Iroegbu CD, Chen W, Wu X, et al.
Cardiovascular diagnosis and therapy 2020; (10(2)):208-222 doi:10.21037/cdt.2020.02.10.
PMID: 32420101 - 4
Endomyocardial fibrosis in adults: multimodality imaging phenotype and independent predictors of mortality.
Hotta VT, Romero CE, Madrini V, et al.
International journal of cardiology 2026; 134929 doi:10.1016/j.ijcard.2026.134929.
PMID: 42790752 - 5
Idiopathic endomyocardial fibrosis in a Western European: a case report.
Théry G, Faroux L, Deleuze P, Metz D
European heart journal. Case reports 2020; (4(3)):1-5 doi:10.1093/ehjcr/ytaa104.
PMID: 32617477 - 6
Surgical Management of The Endomyocardial Fibrosis of Right Ventricle Mimicking Tumor with Recurrent Pulmonary Embolism.
Bzikha R, Queron S
Brazilian journal of cardiovascular surgery 2022; (37(4)):584-586 doi:10.21470/1678-9741-2020-0601e.
PMID: 35976211 - 7
Cardiac surgery in Africa: a thirty-five year experience on open heart surgery in Cote d'Ivoire.
Yangni-Angate KH, Meneas C, Diby F, et al.
Cardiovascular diagnosis and therapy 2016; (6(Suppl 1)):S44-S63 doi:10.21037/cdt.2016.10.06.
PMID: 27904843 - 8
Tricuspid valve relocation with endomyocardial fibrosis removal for Löeffler's endocarditis.
Asai T, Miyashita F, Nota H, Vigers PN
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2019; (56(3)):622-624 doi:10.1093/ejcts/ezy487.
PMID: 30753388 - 9
Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies.
Mbanze J, Cumbane B, Jive R, Mocumbi A
Cardiovascular diagnosis and therapy 2020; (10(2)):279-288 doi:10.21037/cdt.2019.08.07.
PMID: 32420110 - 10
Left ventricle endomyocardial fibrosis: a case report.
Soares RR, Avelar MCM, Zanetti SL, et al.
Journal of medical case reports 2023; (17(1)):361 doi:10.1186/s13256-023-04056-z.
PMID: 37568222 - 11
Exercise Rehabilitation Improves Cardiac Volumes and Functional Capacity in Patients With Endomyocardial Fibrosis: A RANDOMIZED CONTROLLED TRIAL.
Sayegh ALC, Dos Santos MR, Rondon E, et al.
Journal of cardiopulmonary rehabilitation and prevention 2019; (39(6)):373-380 doi:10.1097/HCR.0000000000000445.
PMID: 31397769 - 12
Case report on heart transplantation in endomyocardial fibrosis: 'do not let your guard down'-suspicion of disease recurrence after heart transplantation.
Herrador L, Gayán-Ordás J, Llatjós R, et al.
European heart journal. Case reports 2025; (9(5)):ytaf149 doi:10.1093/ehjcr/ytaf149.
PMID: 40322492 - 13
A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation.
Wagner G, Haumer M, Poelzl G, et al.
BMC cardiovascular disorders 2019; (19(1)):302 doi:10.1186/s12872-019-1243-8.
PMID: 31881943
This page is for informational purposes only and does not constitute medical advice. Your cardiology and cardiac surgery team can assess whether surgery or transplantation is appropriate for you.